Almac Discovery is a new wholly independent member of the Almac Group, focussed exclusively on the discovery and development of novel and innovative approaches to the treatment of cancer and associated conditions.

The primary objective is to establish a high value portfolio of drug discovery programmes in oncology, with the goal of developing a biomarker or diagnostic in parallel with each potential new therapeutic. Projects will generally be taken to clinical proof of concept (or earlier) before out-licensing or partnering for further development.

Almac Discovery has a highly experienced management team and is developing state of the art facilities for drug discovery.

Almac Discovery is working in the areas of:

• Prostate cancer
• Angiogenesis
• Control of metastasis
• Peptide and protein therapeutics

Target finding and in-licensing are key elements of the discovery strategy.

For further details please contact us.